Solanbridge Group, Inc.

OTC: SLNX · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ The Woodlands, TX · MontgomeryCIK 0001165006Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 51

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ Piotroski F, Altman-Z

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-27

Market cap

$476.0k

as of 2026-08-27

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Solanbridge Group, Inc.’s financial profile?

Solanbridge Group, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Nascent Pharma Holdings, Inc.——Stella Diagnostics Inc.——CERo Therapeutics Holdings, Inc.——CaliPharms, Inc.——Canopus Biopharma, Inc.——OJsys, Inc.——

Neighbors

Montgomery →

Western Midstream Partners, LP$3.8B75B+Sterling Infrastructure, Inc.$2.5B80B+Kodiak Gas Services, Inc.$1.3B59C Excelerate Energy, Inc.$1.2B52D Howard Hughes Holdings Inc.——Huntsman Corporation$5.7B65B

Key facts

CEODavid J. Cutler

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersThe Woodlands, TX

ExchangeOTC: SLNX

Employees—

IPO date2007-06-29

Latest filings

8-K2014-11-07 8-K2011-07-22 8-K2011-03-09 8-K2011-01-14 8-K2011-01-12 10-Q2010-11-15 8-K2010-09-24 10-Q2010-08-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.